PHILADELPHIA, Sept. 5, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq:CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that it will present at several upcoming investor conferences, including:
Read more at prnewswire.comCarisma Therapeutics to Present at Upcoming Investor Conferences
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here